Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
3 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
5 Acute myeloid leukemia 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
7 Acute myeloid leukemia 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Acute myeloid leukemia 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
10 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
12 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
13 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
14 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
15 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
16 Acute myeloid leukemia 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
17 Acute myeloid leukemia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
18 Acute myeloid leukemia 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
19 Adherens junction 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
20 Adherens junction 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
21 Adherens junction 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
22 Adherens junction 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
23 Adherens junction 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
24 Adherens junction 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
25 Adherens junction 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
26 Adherens junction 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
27 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
28 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
29 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
30 Adipocytokine signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
31 Adipocytokine signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Adipocytokine signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
33 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lamotrigine 💬 Lamotrigine 7件: 13, 34, 38, 113, 114, 115, 144 💬
34 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
35 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
36 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
37 African trypanosomiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38 African trypanosomiasis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
39 African trypanosomiasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
40 AGE-RAGE signaling pathway in diabetic complications 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
41 AGE-RAGE signaling pathway in diabetic complications 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
42 AGE-RAGE signaling pathway in diabetic complications 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
43 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
44 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
45 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
46 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
47 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
48 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
49 Alcoholic liver disease 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
50 Alcoholic liver disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
51 Alcoholic liver disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
52 Alcoholism 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
53 Alcoholism 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
54 Alcoholism 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
55 Alcoholism 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
56 Alcoholism 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
57 Alcoholism 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
58 Alcoholism 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
59 Alcoholism 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
60 Alcoholism 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
61 Alcoholism 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
62 Alcoholism 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
63 Alcoholism 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
64 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
65 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
66 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
67 Allograft rejection 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
68 Allograft rejection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
69 Allograft rejection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
70 Alzheimer disease 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
71 Alzheimer disease 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
72 Alzheimer disease 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
73 Alzheimer disease 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
74 Alzheimer disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
75 Alzheimer disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
76 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
77 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
78 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
79 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
80 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
81 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
82 Alzheimer disease 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
83 Alzheimer disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
84 Alzheimer disease 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
85 Alzheimer disease 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
86 Alzheimer disease 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
87 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
88 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
89 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
90 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
91 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
92 Alzheimer disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
93 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
94 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
95 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
96 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
97 Amoebiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
98 Amoebiasis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
99 Amoebiasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
100 Amphetamine addiction 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
101 Amphetamine addiction 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
102 AMPK signaling pathway 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
103 AMPK signaling pathway 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 22件:  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
104 AMPK signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
105 AMPK signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
106 AMPK signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
107 Amyotrophic lateral sclerosis 💬
1件: ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
108 Amyotrophic lateral sclerosis 💬
1件: ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
109 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
110 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
111 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
112 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
113 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
114 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
115 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
116 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
117 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
118 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
119 Antigen processing and presentation 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
120 Antigen processing and presentation 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
121 Antigen processing and presentation 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
122 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
123 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
124 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
125 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
126 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
127 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
128 Apelin signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
129 Apelin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
130 Apelin signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
131 Apelin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
132 Apelin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
133 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
134 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
135 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
136 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
137 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
138 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
139 Apoptosis 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
140 Apoptosis 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
141 Apoptosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
142 Apoptosis 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
143 Apoptosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
144 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
145 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
146 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
147 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
148 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
149 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
150 Arachidonic acid metabolism 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
151 Asthma 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
152 Asthma 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
153 Asthma 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
154 Autoimmune thyroid disease 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
155 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
156 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
157 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
158 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
159 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
160 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
161 Autophagy - animal 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
162 Autophagy - animal 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
163 Autophagy - animal 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
164 Autophagy - animal 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
165 Autophagy - animal 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
166 Autophagy - other 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
167 Autophagy - other 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
168 Autophagy - other 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
169 Axon guidance 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
170 Axon guidance 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
171 Axon guidance 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
172 Axon guidance 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
173 Axon guidance 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
174 Axon guidance 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
175 Axon guidance 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
176 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
177 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
178 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
179 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
180 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
181 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
182 B cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
183 B cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
184 Bacterial invasion of epithelial cells 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
185 Bacterial invasion of epithelial cells 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
186 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
187 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
188 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
189 Bile secretion 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
190 Bile secretion 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 22件:  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
191 Bladder cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
192 Bladder cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
193 Bladder cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
194 Bladder cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
195 Bladder cancer 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
196 Bladder cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
197 Bladder cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
198 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
199 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
200 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
201 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
202 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
203 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
204 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
205 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
206 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
207 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
208 Bladder cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
209 Bladder cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
210 Breast cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
211 Breast cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
212 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
213 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
214 Breast cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
215 Breast cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
216 Breast cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
217 Breast cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
218 Breast cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
219 Breast cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
220 Breast cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
221 Breast cancer 💬
1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬
222 Breast cancer 💬
1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬
223 Breast cancer 💬
1件: FLT4 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
224 Breast cancer 💬
2件: FLT4, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
225 Breast cancer 💬
2件: FLT4, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
226 Breast cancer 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
227 Breast cancer 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
228 Breast cancer 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
229 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
230 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
231 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
232 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
233 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
234 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
235 Breast cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
236 Breast cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
237 Breast cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
238 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
239 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
240 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
241 C-type lectin receptor signaling pathway 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
242 C-type lectin receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
243 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
244 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
245 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
246 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
247 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
248 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
249 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
250 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
251 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
252 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
253 Cadherin signaling 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
254 Cadherin signaling 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
255 Cadherin signaling 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
256 Cadherin signaling 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
257 Cadherin signaling 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
258 Cadherin signaling 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
259 Cadherin signaling 💬
2件: FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
260 Cadherin signaling 💬
2件: FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
261 Cadherin signaling 💬
2件: FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
262 Cadherin signaling 💬
4件: FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
263 Cadherin signaling 💬
4件: FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
264 Cadherin signaling 💬
4件: FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
265 Cadherin signaling 💬
4件: FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
266 Cadherin signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
267 Cadherin signaling 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
268 Cadherin signaling 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
269 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
270 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
271 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
272 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
273 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
274 Cadherin signaling 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
275 Cadherin signaling 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
276 Cadherin signaling 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
277 Cadherin signaling 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
278 Cadherin signaling 💬
1件: SCN5A 💬 Lamotrigine 💬 Lamotrigine 7件: 13, 34, 38, 113, 114, 115, 144 💬
279 Cadherin signaling 💬
1件: SCN5A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
280 Cadherin signaling 💬
1件: SCN5A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
281 Cadherin signaling 💬
1件: SCN5A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
282 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
283 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
284 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
285 Calcium signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
286 Calcium signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
287 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
288 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
289 Calcium signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
290 Calcium signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
291 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
292 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
293 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
294 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
295 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
296 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
297 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
298 Calcium signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
299 Calcium signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
300 Calcium signaling pathway 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
301 Calcium signaling pathway 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
302 Calcium signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
303 Calcium signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
304 Calcium signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
305 cAMP signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
306 cAMP signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
307 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
308 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
309 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
310 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
311 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
312 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
313 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
314 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
315 Cell adhesion molecule (CAM) interaction 💬
1件: PDCD1 💬 Retifanlimab 💬 Retifanlimab 1件: 34 💬
316 Cell cycle 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
317 Cell cycle 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
318 Cell cycle 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
319 Cell cycle 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
320 Cellular senescence 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
321 Cellular senescence 💬
2件: IL1A, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
322 Cellular senescence 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
323 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
324 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
325 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
326 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
327 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
328 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
329 Cellular senescence 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
330 Cellular senescence 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
331 Cellular senescence 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
332 Cellular senescence 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
333 Cellular senescence 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
334 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
335 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
336 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
337 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
338 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
339 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
340 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
341 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
342 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
343 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
344 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
345 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
346 Central carbon metabolism in cancer 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
347 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
348 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
349 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
350 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
351 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
352 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
353 Central carbon metabolism in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
354 Central carbon metabolism in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
355 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
356 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
357 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
358 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
359 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
360 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
361 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
362 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
363 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
364 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
365 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
366 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
367 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
368 Chagas disease 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
369 Chagas disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
370 Chagas disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
371 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
372 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
373 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
374 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
375 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
376 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
377 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
378 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
379 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
380 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
381 Chemical carcinogenesis - reactive oxygen species 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
382 Chemical carcinogenesis - reactive oxygen species 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
383 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
384 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
385 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
386 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
387 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
388 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
389 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
390 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
391 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
392 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
393 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
394 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
395 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
396 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
397 Chemical carcinogenesis - reactive oxygen species 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
398 Chemical carcinogenesis - reactive oxygen species 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
399 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
400 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
401 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
402 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
403 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
404 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
405 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
406 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
407 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
408 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
409 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
410 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
411 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
412 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
413 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
414 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
415 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
416 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
417 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
418 Chemical carcinogenesis - receptor activation 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
419 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
420 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
421 Chemokine signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
422 Chemokine signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
423 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
424 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
425 Chemokine signaling pathway 💬
1件: CCL2 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
426 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
427 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
428 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
429 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
430 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
431 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
432 Choline metabolism in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
433 Choline metabolism in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
434 Choline metabolism in cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
435 Choline metabolism in cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
436 Choline metabolism in cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
437 Choline metabolism in cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
438 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
439 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
440 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
441 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
442 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
443 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
444 Choline metabolism in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
445 Choline metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
446 Choline metabolism in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
447 Choline metabolism in cancer 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
448 Choline metabolism in cancer 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
449 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
450 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
451 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
452 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
453 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
454 Cholinergic synapse 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
455 Cholinergic synapse 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
456 Cholinergic synapse 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
457 Cholinergic synapse 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
458 Cholinergic synapse 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
459 Cholinergic synapse 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
460 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
461 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
462 Chronic myeloid leukemia 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
463 Chronic myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
464 Chronic myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
465 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
466 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
467 Chronic myeloid leukemia 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
468 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
469 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
470 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
471 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
472 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
473 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
474 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
475 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
476 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
477 Cocaine addiction 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
478 Cocaine addiction 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
479 Colorectal cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
480 Colorectal cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
481 Colorectal cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
482 Colorectal cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
483 Colorectal cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
484 Colorectal cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
485 Colorectal cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
486 Colorectal cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
487 Colorectal cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
488 Colorectal cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
489 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
490 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
491 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
492 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
493 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
494 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
495 Colorectal cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
496 Colorectal cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
497 Colorectal cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
498 Coronavirus disease 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
499 Coronavirus disease 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
500 Coronavirus disease 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
501 Coronavirus disease 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
502 Coronavirus disease 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
503 Coronavirus disease 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
504 Coronavirus disease 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
505 Coronavirus disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
506 Coronavirus disease 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
507 Coronavirus disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
508 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
509 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
510 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
511 Cushing syndrome 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
512 Cushing syndrome 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
513 Cushing syndrome 💬
1件: BRAF 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
514 Cushing syndrome 💬
1件: BRAF 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
515 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
516 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
517 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
518 Cushing syndrome 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
519 Cushing syndrome 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
520 Cushing syndrome 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
521 Cushing syndrome 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
522 Cushing syndrome 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
523 Cushing syndrome 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
524 Cushing syndrome 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
525 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
526 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
527 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
528 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
529 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
530 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
531 Cysteine and methionine metabolism 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
532 Cytokine-cytokine receptor interaction 💬
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
533 Cytokine-cytokine receptor interaction 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
534 Cytokine-cytokine receptor interaction 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
535 Cytokine-cytokine receptor interaction 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
536 Cytokine-cytokine receptor interaction 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
537 Cytokine-cytokine receptor interaction 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
538 Cytosolic DNA-sensing pathway 💬
2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
539 Cytosolic DNA-sensing pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
540 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
541 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
542 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
543 Dilated cardiomyopathy 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
544 Dilated cardiomyopathy 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
545 Dilated cardiomyopathy 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
546 Dopaminergic synapse 💬
1件: SCN1A 💬 Lamotrigine 💬 Lamotrigine 7件: 13, 34, 38, 113, 114, 115, 144 💬
547 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
548 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
549 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
550 Dopaminergic synapse 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
551 Dopaminergic synapse 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
552 Drug metabolism - other enzymes 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
553 Drug metabolism - other enzymes 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
554 ECM-receptor interaction 💬
1件: SV2A 💬 Levetiracetam 💬 Levetiracetam 7件:  2 ,  4 ,  6 , 13, 34, 149, 307 💬
555 Efferocytosis 💬
1件: AXL 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
556 Efferocytosis 💬
1件: AXL 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
557 Efferocytosis 💬
2件: DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
558 Efferocytosis 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
559 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
560 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
561 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
562 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
563 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
564 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
565 Efferocytosis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
566 Efferocytosis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
567 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
568 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
569 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
570 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
571 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
572 Endocrine and other factor-regulated calcium reabsorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
573 Endocytosis 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
574 Endocytosis 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
575 Endocytosis 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
576 Endocytosis 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
577 Endocytosis 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
578 Endocytosis 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
579 Endocytosis 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
580 Endocytosis 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
581 Endocytosis 💬
1件: PDGFRA 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
582 Endocytosis 💬
1件: PDGFRA 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
583 Endocytosis 💬
1件: PDGFRA 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
584 Endometrial cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
585 Endometrial cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
586 Endometrial cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
587 Endometrial cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
588 Endometrial cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
589 Endometrial cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
590 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
591 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
592 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
593 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
594 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
595 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
596 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
597 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
598 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
599 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
600 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
601 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
602 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
603 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
604 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
605 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
606 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
607 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
608 Epstein-Barr virus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
609 Epstein-Barr virus infection 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
610 Epstein-Barr virus infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
611 Epstein-Barr virus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
612 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
613 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
614 ErbB signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
615 ErbB signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
616 ErbB signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
617 ErbB signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
618 ErbB signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
619 ErbB signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
620 ErbB signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
621 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
622 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
623 ErbB signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
624 ErbB signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
625 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
626 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
627 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
628 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
629 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
630 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
631 ErbB signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
632 ErbB signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
633 ErbB signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
634 Estrogen signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
635 Estrogen signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
636 Estrogen signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
637 Estrogen signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
638 Estrogen signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
639 Estrogen signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
640 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
641 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
642 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
643 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
644 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
645 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
646 Estrogen signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
647 Estrogen signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
648 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
649 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
650 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
651 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
652 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
653 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
654 Fc epsilon RI signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
655 Fc epsilon RI signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
656 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
657 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
658 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
659 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
660 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
661 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
662 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
663 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
664 Fc gamma R-mediated phagosome formation 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
665 Fc gamma R-mediated phagosome formation 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
666 Fc gamma R-mediated phagosome formation 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
667 Fluid shear stress and atherosclerosis 💬
4件: CCL2, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
668 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
669 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
670 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
671 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
672 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
673 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
674 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
675 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
676 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
677 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
678 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
679 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
680 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
681 Focal adhesion 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
682 Focal adhesion 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
683 Focal adhesion 💬
5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
684 Focal adhesion 💬
5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
685 Focal adhesion 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
686 Focal adhesion 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
687 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
688 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
689 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
690 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
691 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
692 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
693 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
694 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
695 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
696 Focal adhesion 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
697 Focal adhesion 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
698 Focal adhesion 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
699 Focal adhesion 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
700 Focal adhesion 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
701 Focal adhesion 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
702 Focal adhesion 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
703 Focal adhesion 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
704 Focal adhesion 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
705 Focal adhesion 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
706 Focal adhesion 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
707 Focal adhesion 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
708 Focal adhesion 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
709 Folate biosynthesis 💬
2件: DHFR, DHFR2 💬 Methotrexate 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
710 Folate biosynthesis 💬
2件: DHFR, DHFR2 💬 Methotrexate sodium 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
711 Folate transport and metabolism 💬
2件: DHFR, DHFR2 💬 Methotrexate 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
712 Folate transport and metabolism 💬
2件: DHFR, DHFR2 💬 Methotrexate sodium 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
713 FoxO signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
714 FoxO signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
715 FoxO signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
716 FoxO signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
717 FoxO signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
718 FoxO signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
719 FoxO signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
720 FoxO signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
721 FoxO signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
722 FoxO signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
723 FoxO signaling pathway 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
724 FoxO signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
725 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
726 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
727 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
728 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
729 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
730 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
731 GABAergic synapse 💬
3件: ABAT, GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
732 GABAergic synapse 💬
3件: ABAT, GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
733 GABAergic synapse 💬
3件: ABAT, GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
734 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
735 Gap junction 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
736 Gap junction 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
737 Gap junction 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
738 Gap junction 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
739 Gap junction 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
740 Gap junction 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
741 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
742 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
743 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
744 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
745 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
746 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
747 Gap junction 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
748 Gap junction 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
749 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
750 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
751 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
752 Gap junction 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
753 Gap junction 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
754 Gap junction 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
755 Gap junction 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
756 Gap junction 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
757 Gap junction 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
758 Gastric cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
759 Gastric cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
760 Gastric cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
761 Gastric cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
762 Gastric cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
763 Gastric cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
764 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
765 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
766 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
767 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
768 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
769 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
770 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
771 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
772 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
773 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
774 Gastric cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
775 Gastric cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
776 Gastric cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
777 Gastric cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
778 Gastric cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
779 Glioma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
780 Glioma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
781 Glioma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
782 Glioma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
783 Glioma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
784 Glioma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
785 Glioma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
786 Glioma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
787 Glioma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
788 Glioma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
789 Glioma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
790 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
791 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
792 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
793 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
794 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
795 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
796 Glioma 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
797 Glioma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
798 Glioma 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
799 Glioma 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
800 Glioma 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
801 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
802 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
803 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
804 Glutathione metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
805 Glutathione metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
806 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
807 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
808 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
809 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
810 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
811 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
812 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
813 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
814 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
815 GnRH secretion 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
816 GnRH secretion 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
817 GnRH signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
818 GnRH signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
819 GnRH signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
820 GnRH signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
821 GnRH signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
822 GnRH signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
823 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
824 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
825 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
826 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
827 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
828 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
829 GnRH signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
830 GnRH signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
831 Graft-versus-host disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
832 Graft-versus-host disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
833 Graft-versus-host disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
834 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
835 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
836 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
837 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
838 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
839 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
840 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
841 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
842 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
843 Growth hormone synthesis, secretion and action 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
844 Growth hormone synthesis, secretion and action 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
845 Hematopoietic cell lineage 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
846 Hematopoietic cell lineage 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
847 Hematopoietic cell lineage 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
848 Hematopoietic cell lineage 💬
2件: FLT3, KIT 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
849 Hematopoietic cell lineage 💬
2件: FLT3, KIT 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
850 Hematopoietic cell lineage 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
851 Hematopoietic cell lineage 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
852 Hematopoietic cell lineage 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
853 Hematopoietic cell lineage 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
854 Hematopoietic cell lineage 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
855 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
856 Hematopoietic cell lineage 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
857 Hepatitis B 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
858 Hepatitis B 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
859 Hepatitis B 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
860 Hepatitis B 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
861 Hepatitis B 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
862 Hepatitis B 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
863 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
864 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
865 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
866 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
867 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
868 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
869 Hepatitis B 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
870 Hepatitis C 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
871 Hepatitis C 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
872 Hepatitis C 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
873 Hepatitis C 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
874 Hepatitis C 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
875 Hepatitis C 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
876 Hepatitis C 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
877 Hepatitis C 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
878 Hepatitis C 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
879 Hepatitis C 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
880 Hepatitis C 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
881 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
882 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
883 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
884 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
885 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
886 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
887 Hepatitis C 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
888 Hepatitis C 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
889 Hepatitis C 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
890 Hepatocellular carcinoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
891 Hepatocellular carcinoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
892 Hepatocellular carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
893 Hepatocellular carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
894 Hepatocellular carcinoma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
895 Hepatocellular carcinoma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
896 Hepatocellular carcinoma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
897 Hepatocellular carcinoma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
898 Hepatocellular carcinoma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
899 Hepatocellular carcinoma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
900 Hepatocellular carcinoma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
901 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
902 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
903 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
904 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
905 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
906 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
907 Hepatocellular carcinoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
908 Hepatocellular carcinoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
909 Hepatocellular carcinoma 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
910 Hepatocellular carcinoma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
911 Hepatocellular carcinoma 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
912 Herpes simplex virus 1 infection 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
913 Herpes simplex virus 1 infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
914 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
915 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
916 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
917 Herpes simplex virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
918 HIF-1 signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
919 HIF-1 signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
920 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
921 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
922 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
923 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
924 HIF-1 signaling pathway 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
925 HIF-1 signaling pathway 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
926 HIF-1 signaling pathway 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
927 HIF-1 signaling pathway 💬
1件: FLT1 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
928 HIF-1 signaling pathway 💬
1件: FLT1 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
929 HIF-1 signaling pathway 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
930 HIF-1 signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
931 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
932 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
933 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
934 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
935 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
936 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
937 HIF-1 signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
938 HIF-1 signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
939 HIF-1 signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
940 HIF-1 signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
941 HIF-1 signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
942 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
943 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
944 Human cytomegalovirus infection 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
945 Human cytomegalovirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
946 Human cytomegalovirus infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
947 Human cytomegalovirus infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
948 Human cytomegalovirus infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
949 Human cytomegalovirus infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
950 Human cytomegalovirus infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
951 Human cytomegalovirus infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
952 Human cytomegalovirus infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
953 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
954 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
955 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
956 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
957 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
958 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
959 Human cytomegalovirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
960 Human cytomegalovirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
961 Human cytomegalovirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
962 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
963 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
964 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
965 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
966 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
967 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
968 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
969 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
970 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
971 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
972 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
973 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
974 Human cytomegalovirus infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
975 Human cytomegalovirus infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
976 Human cytomegalovirus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
977 Human cytomegalovirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
978 Human cytomegalovirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
979 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
980 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
981 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
982 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
983 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
984 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
985 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
986 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
987 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
988 Human immunodeficiency virus 1 infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
989 Human immunodeficiency virus 1 infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
990 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
991 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
992 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
993 Human papillomavirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
994 Human papillomavirus infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
995 Human papillomavirus infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
996 Human papillomavirus infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
997 Human papillomavirus infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
998 Human papillomavirus infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
999 Human papillomavirus infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1000 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1001 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1002 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1003 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1004 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1005 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1006 Human papillomavirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1007 Human papillomavirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1008 Human papillomavirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1009 Human papillomavirus infection 💬
1件: PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1010 Human papillomavirus infection 💬
1件: PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1011 Human papillomavirus infection 💬
1件: PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1012 Human papillomavirus infection 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1013 Human papillomavirus infection 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1014 Human papillomavirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1015 Human papillomavirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1016 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1017 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1018 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1019 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1020 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1021 Human papillomavirus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1022 Human papillomavirus infection 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1023 Human papillomavirus infection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1024 Human papillomavirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1025 Human papillomavirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1026 Human T-cell leukemia virus 1 infection 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1027 Human T-cell leukemia virus 1 infection 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1028 Human T-cell leukemia virus 1 infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1029 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1030 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1031 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1032 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1033 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1034 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1035 Human T-cell leukemia virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1036 Huntington disease 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1037 Huntington disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1038 Huntington disease 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1039 Huntington disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1040 Huntington disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1041 Huntington disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1042 Huntington disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1043 Hypertrophic cardiomyopathy 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1044 Hypertrophic cardiomyopathy 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1045 Hypertrophic cardiomyopathy 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1046 IgSF CAM signaling 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1047 IgSF CAM signaling 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1048 IgSF CAM signaling 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1049 IgSF CAM signaling 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1050 IgSF CAM signaling 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1051 IgSF CAM signaling 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1052 IgSF CAM signaling 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1053 IgSF CAM signaling 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1054 IgSF CAM signaling 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1055 IgSF CAM signaling 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1056 IgSF CAM signaling 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1057 IgSF CAM signaling 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1058 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1059 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1060 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1061 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1062 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1063 IgSF CAM signaling 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1064 IgSF CAM signaling 💬
1件: SCN8A 💬 Lamotrigine 💬 Lamotrigine 7件: 13, 34, 38, 113, 114, 115, 144 💬
1065 IgSF CAM signaling 💬
1件: SCN8A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
1066 IgSF CAM signaling 💬
1件: SCN8A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
1067 IgSF CAM signaling 💬
1件: SCN8A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
1068 IgSF CAM signaling 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1069 IgSF CAM signaling 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1070 IgSF CAM signaling 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1071 IgSF CAM signaling 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1072 IL-17 signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1073 IL-17 signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1074 IL-17 signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1075 IL-17 signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1076 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1077 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1078 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1079 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1080 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1081 IL-17 signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1082 Inflammatory bowel disease 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1083 Inflammatory bowel disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1084 Inflammatory bowel disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1085 Inflammatory mediator regulation of TRP channels 💬
1件: IL1B 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1086 Influenza A 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1087 Influenza A 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1088 Influenza A 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1089 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1090 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1091 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1092 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1093 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1094 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1095 Influenza A 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1096 Influenza A 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1097 Influenza A 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1098 Influenza A 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1099 Insulin resistance 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1100 Insulin resistance 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1101 Insulin resistance 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1102 Insulin resistance 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1103 Insulin resistance 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1104 Insulin resistance 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1105 Insulin signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1106 Insulin signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1107 Insulin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1108 Insulin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1109 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1110 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1111 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1112 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1113 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1114 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1115 Insulin signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1116 Insulin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1117 Insulin signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1118 Integrated stress response (ISR) signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1119 Integrated stress response (ISR) signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1120 Integrated stress response (ISR) signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1121 Integrin signaling 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1122 Integrin signaling 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1123 Integrin signaling 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1124 Integrin signaling 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1125 Integrin signaling 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1126 Integrin signaling 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1127 Integrin signaling 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1128 Integrin signaling 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1129 Integrin signaling 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1130 Integrin signaling 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1131 Integrin signaling 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1132 Integrin signaling 💬
3件: FLT4, KDR, PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1133 Integrin signaling 💬
3件: FLT4, KDR, PDGFRB 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1134 Integrin signaling 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1135 Integrin signaling 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1136 Integrin signaling 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1137 Integrin signaling 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1138 Integrin signaling 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1139 Integrin signaling 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1140 Integrin signaling 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1141 Integrin signaling 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1142 Integrin signaling 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1143 Integrin signaling 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1144 Intestinal immune network for IgA production 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1145 Intestinal immune network for IgA production 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1146 JAK-STAT signaling pathway 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1147 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1148 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1149 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1150 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1151 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1152 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1153 JAK-STAT signaling pathway 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1154 JAK-STAT signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1155 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1156 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1157 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1158 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1159 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1160 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1161 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1162 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1163 JAK-STAT signaling pathway 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1164 JAK-STAT signaling pathway 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1165 Kaposi sarcoma-associated herpesvirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1166 Kaposi sarcoma-associated herpesvirus infection 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1167 Kaposi sarcoma-associated herpesvirus infection 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1168 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1169 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1170 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1171 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1172 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1173 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1174 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1175 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1176 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1177 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1178 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1179 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1180 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1181 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1182 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1183 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1184 Kaposi sarcoma-associated herpesvirus infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1185 Kaposi sarcoma-associated herpesvirus infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1186 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1187 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1188 Legionellosis 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1189 Legionellosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1190 Legionellosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1191 Leishmaniasis 💬
4件: IL10, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1192 Leishmaniasis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1193 Leishmaniasis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1194 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1195 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1196 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1197 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1198 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1199 Leishmaniasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1200 Leishmaniasis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1201 Lipid and atherosclerosis 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1202 Lipid and atherosclerosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1203 Lipid and atherosclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1204 Long-term depression 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1205 Long-term depression 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1206 Long-term depression 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1207 Long-term depression 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1208 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1209 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1210 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1211 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1212 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1213 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1214 Long-term potentiation 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1215 Long-term potentiation 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1216 Long-term potentiation 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1217 Long-term potentiation 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1218 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1219 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1220 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1221 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1222 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1223 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1224 Longevity regulating pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1225 Longevity regulating pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1226 Longevity regulating pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1227 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1228 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1229 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1230 Lysosome biogenesis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1231 Lysosome biogenesis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1232 Lysosome biogenesis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1233 Lysosome biogenesis 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1234 Malaria 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1235 Malaria 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1236 Malaria 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1237 Malaria 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1238 Malaria 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1239 MAPK signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1240 MAPK signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1241 MAPK signaling pathway 💬
8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1242 MAPK signaling pathway 💬
8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1243 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1244 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1245 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1246 MAPK signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1247 MAPK signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1248 MAPK signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1249 MAPK signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1250 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1251 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1252 MAPK signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1253 MAPK signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1254 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1255 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1256 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1257 MAPK signaling pathway 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1258 MAPK signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1259 MAPK signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1260 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1261 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1262 MAPK signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1263 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1264 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1265 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1266 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1267 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1268 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1269 MAPK signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1270 MAPK signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1271 MAPK signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1272 MAPK signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1273 Measles 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1274 Measles 💬
3件: IL1A, IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1275 Measles 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1276 Measles 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1277 Melanogenesis 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1278 Melanogenesis 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1279 Melanogenesis 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1280 Melanogenesis 💬
1件: KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1281 Melanogenesis 💬
1件: KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1282 Melanogenesis 💬
2件: KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1283 Melanogenesis 💬
2件: KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1284 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1285 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1286 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1287 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1288 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1289 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1290 Melanoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1291 Melanoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1292 Melanoma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1293 Melanoma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1294 Melanoma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1295 Melanoma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1296 Melanoma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1297 Melanoma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1298 Melanoma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1299 Melanoma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1300 Melanoma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1301 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1302 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1303 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1304 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1305 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1306 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1307 Melanoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1308 Melanoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1309 Melanoma 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1310 Melanoma 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1311 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1312 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1313 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1314 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1315 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1316 MicroRNAs in cancer 💬
3件: ABL1, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1317 MicroRNAs in cancer 💬
1件: CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1318 MicroRNAs in cancer 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
1319 MicroRNAs in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1320 MicroRNAs in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1321 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1322 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1323 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1324 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1325 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1326 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1327 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1328 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1329 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1330 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1331 MicroRNAs in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1332 MicroRNAs in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1333 MicroRNAs in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1334 MicroRNAs in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1335 MicroRNAs in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1336 MicroRNAs in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1337 MicroRNAs in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1338 MicroRNAs in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1339 MicroRNAs in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1340 MicroRNAs in cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1341 MicroRNAs in cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1342 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1343 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1344 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1345 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1346 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1347 MicroRNAs in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1348 MicroRNAs in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1349 Mineral absorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
1350 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1351 Motor proteins 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1352 Motor proteins 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1353 Motor proteins 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1354 Motor proteins 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1355 mTOR signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1356 mTOR signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1357 mTOR signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1358 mTOR signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1359 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1360 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1361 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1362 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1363 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1364 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1365 mTOR signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1366 mTOR signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1367 mTOR signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1368 mTOR signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1369 mTOR signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1370 mTOR signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1371 Natural killer cell mediated cytotoxicity 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1372 Natural killer cell mediated cytotoxicity 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1373 Natural killer cell mediated cytotoxicity 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1374 Natural killer cell mediated cytotoxicity 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1375 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1376 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1377 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1378 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1379 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1380 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1381 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1382 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1383 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1384 Necroptosis 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1385 Necroptosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1386 Necroptosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1387 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1388 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1389 Neuroactive ligand signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1390 Neuroactive ligand signaling 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1391 Neuroactive ligand signaling 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1392 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1393 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1394 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1395 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1396 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1397 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1398 Neurotrophin signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1399 Neurotrophin signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1400 Neurotrophin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1401 Neurotrophin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1402 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1403 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1404 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1405 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1406 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1407 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1408 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1409 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1410 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1411 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1412 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1413 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1414 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1415 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1416 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1417 Neutrophil extracellular trap formation 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1418 Neutrophil extracellular trap formation 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1419 Neutrophil extracellular trap formation 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1420 NF-kappa B signaling pathway 💬
2件: IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1421 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1422 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1423 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1424 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1425 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1426 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1427 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1428 NF-kappa B signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1429 NF-kappa B signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1430 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1431 NOD-like receptor signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1432 NOD-like receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1433 NOD-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1434 Non-alcoholic fatty liver disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1435 Non-alcoholic fatty liver disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1436 Non-alcoholic fatty liver disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1437 Non-small cell lung cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1438 Non-small cell lung cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1439 Non-small cell lung cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1440 Non-small cell lung cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1441 Non-small cell lung cancer 💬
3件: BRAF, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1442 Non-small cell lung cancer 💬
3件: BRAF, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1443 Non-small cell lung cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1444 Non-small cell lung cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1445 Non-small cell lung cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1446 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1447 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1448 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1449 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1450 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1451 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1452 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1453 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1454 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1455 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1456 Non-small cell lung cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1457 Non-small cell lung cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1458 Non-small cell lung cancer 💬
1件: RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1459 Non-small cell lung cancer 💬
1件: RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1460 One carbon pool by folate 💬
2件: DHFR, DHFR2 💬 Methotrexate 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
1461 One carbon pool by folate 💬
2件: DHFR, DHFR2 💬 Methotrexate sodium 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
1462 Oocyte meiosis 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1463 Oocyte meiosis 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1464 Oocyte meiosis 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1465 Oocyte meiosis 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1466 Oocyte meiosis 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1467 Oocyte meiosis 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1468 Osteoclast differentiation 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1469 Osteoclast differentiation 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1470 Osteoclast differentiation 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1471 Osteoclast differentiation 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1472 Osteoclast differentiation 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1473 Osteoclast differentiation 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1474 Osteoclast differentiation 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1475 Osteoclast differentiation 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1476 Osteoclast differentiation 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1477 Osteoclast differentiation 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1478 Osteoclast differentiation 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1479 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1480 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1481 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1482 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1483 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1484 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1485 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1486 Oxytocin signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1487 Oxytocin signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1488 Oxytocin signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1489 Oxytocin signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1490 Oxytocin signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1491 Oxytocin signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1492 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1493 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1494 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1495 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1496 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1497 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1498 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1499 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1500 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1501 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1502 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1503 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1504 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1505 Oxytocin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1506 Oxytocin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1507 p53 signaling pathway 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1508 Pancreatic cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1509 Pancreatic cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1510 Pancreatic cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1511 Pancreatic cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1512 Pancreatic cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1513 Pancreatic cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1514 Pancreatic cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1515 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1516 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1517 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1518 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1519 Pancreatic cancer 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1520 Pancreatic cancer 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1521 Pancreatic cancer 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1522 Pancreatic cancer 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1523 Pancreatic cancer 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1524 Pancreatic cancer 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1525 Pancreatic cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1526 Pancreatic cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1527 Pancreatic cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1528 Pancreatic cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1529 Pancreatic cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1530 Parathyroid hormone synthesis, secretion and action 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1531 Parathyroid hormone synthesis, secretion and action 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1532 Parathyroid hormone synthesis, secretion and action 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1533 Parathyroid hormone synthesis, secretion and action 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1534 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1535 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1536 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1537 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1538 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1539 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1540 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1541 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1542 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1543 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1544 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1545 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1546 Parathyroid hormone synthesis, secretion and action 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
1547 Parkinson disease 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1548 Parkinson disease 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1549 Parkinson disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1550 Parkinson disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1551 Parkinson disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1552 Parkinson disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1553 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1554 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1555 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1556 Pathogenic Escherichia coli infection 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1557 Pathogenic Escherichia coli infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1558 Pathogenic Escherichia coli infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1559 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1560 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1561 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1562 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1563 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1564 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1565 Pathways in cancer 💬
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1566 Pathways in cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1567 Pathways in cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1568 Pathways in cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1569 Pathways in cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1570 Pathways in cancer 💬
7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1571 Pathways in cancer 💬
7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1572 Pathways in cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1573 Pathways in cancer 💬
7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1574 Pathways in cancer 💬
7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1575 Pathways in cancer 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1576 Pathways in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1577 Pathways in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1578 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1579 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1580 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1581 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1582 Pathways in cancer 💬
1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬
1583 Pathways in cancer 💬
1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬
1584 Pathways in cancer 💬
1件: FLT4 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1585 Pathways in cancer 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1586 Pathways in cancer 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1587 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1588 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1589 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1590 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1591 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1592 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1593 Pathways in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1594 Pathways in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1595 Pathways in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1596 Pathways in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1597 Pathways in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1598 Pathways in cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1599 Pathways in cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1600 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1601 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1602 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1603 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1604 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1605 Pathways in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1606 Pathways in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1607 Pathways of neurodegeneration - multiple diseases 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1608 Pathways of neurodegeneration - multiple diseases 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1609 Pathways of neurodegeneration - multiple diseases 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1610 Pathways of neurodegeneration - multiple diseases 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1611 Pathways of neurodegeneration - multiple diseases 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1612 Pathways of neurodegeneration - multiple diseases 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1613 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1614 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1615 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1616 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1617 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1618 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1619 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1620 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1621 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1622 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1623 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1624 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1625 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1626 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1627 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1628 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1629 Pathways of neurodegeneration - multiple diseases 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1630 Pathways of neurodegeneration - multiple diseases 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1631 Pathways of neurodegeneration - multiple diseases 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1632 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1633 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1634 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1635 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1636 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1637 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1638 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1639 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1640 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1641 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1642 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1643 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1644 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1645 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1646 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1647 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1648 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1649 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1650 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1651 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1652 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1653 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: PDCD1 💬 Retifanlimab 💬 Retifanlimab 1件: 34 💬
1654 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1655 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1656 Pertussis 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1657 Pertussis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1658 Pertussis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1659 Phagocytosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1660 Phagocytosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1661 Phagocytosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1662 Phagocytosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1663 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1664 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1665 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1666 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1667 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1668 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1669 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1670 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1671 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1672 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1673 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1674 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1675 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1676 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1677 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1678 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1679 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1680 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1681 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1682 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1683 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1684 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1685 PI3K-Akt signaling pathway 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1686 PI3K-Akt signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1687 PI3K-Akt signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1688 PI3K-Akt signaling pathway 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1689 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1690 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1691 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1692 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1693 PI3K-Akt signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1694 PI3K-Akt signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1695 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1696 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1697 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1698 PI3K-Akt signaling pathway 💬
7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1699 PI3K-Akt signaling pathway 💬
7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1700 PI3K-Akt signaling pathway 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1701 PI3K-Akt signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1702 PI3K-Akt signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1703 PI3K-Akt signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1704 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1705 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1706 PI3K-Akt signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1707 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1708 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1709 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1710 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1711 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1712 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1713 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1714 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1715 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1716 PI3K-Akt signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1717 PI3K-Akt signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1718 Platelet activation 💬
1件: PTGS1 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1719 Platelet activation 💬
1件: PTGS1 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1720 Platelet activation 💬
1件: PTGS1 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1721 Platelet activation 💬
1件: PTGS1 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1722 Platelet activation 💬
1件: PTGS1 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1723 Platelet activation 💬
1件: PTGS1 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1724 Prion disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1725 Prion disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1726 Prion disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1727 Prion disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1728 Prion disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1729 Prion disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1730 Prion disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1731 Progesterone-mediated oocyte maturation 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1732 Progesterone-mediated oocyte maturation 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1733 Progesterone-mediated oocyte maturation 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1734 Progesterone-mediated oocyte maturation 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1735 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1736 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1737 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1738 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1739 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1740 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1741 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1742 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1743 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1744 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1745 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1746 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1747 Prolactin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1748 Prolactin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1749 Propanoate metabolism 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1750 Propanoate metabolism 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1751 Propanoate metabolism 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
1752 Prostate cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1753 Prostate cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1754 Prostate cancer 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1755 Prostate cancer 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1756 Prostate cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1757 Prostate cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1758 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1759 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1760 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1761 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1762 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1763 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1764 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1765 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1766 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1767 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1768 Prostate cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1769 Prostate cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1770 Prostate cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1771 Prostate cancer 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1772 Prostate cancer 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1773 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1774 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1775 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1776 Proteoglycans in cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1777 Proteoglycans in cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1778 Proteoglycans in cancer 💬
3件: BRAF, KDR, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1779 Proteoglycans in cancer 💬
3件: BRAF, KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1780 Proteoglycans in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1781 Proteoglycans in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1782 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1783 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1784 Proteoglycans in cancer 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1785 Proteoglycans in cancer 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1786 Proteoglycans in cancer 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1787 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1788 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1789 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1790 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1791 Proteoglycans in cancer 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1792 Proteoglycans in cancer 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1793 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1794 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1795 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1796 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1797 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1798 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1799 Proteoglycans in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1800 Proteoglycans in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1801 Proteoglycans in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1802 Proteoglycans in cancer 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1803 Proteoglycans in cancer 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1804 Proteoglycans in cancer 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1805 Proteoglycans in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1806 Proteoglycans in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1807 Purine metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
1808 Purine metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
1809 Pyrimidine metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
1810 Pyrimidine metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
1811 Rap1 signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1812 Rap1 signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1813 Rap1 signaling pathway 💬
6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1814 Rap1 signaling pathway 💬
6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1815 Rap1 signaling pathway 💬
7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1816 Rap1 signaling pathway 💬
7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1817 Rap1 signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1818 Rap1 signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1819 Rap1 signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1820 Rap1 signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1821 Rap1 signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1822 Rap1 signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1823 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1824 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1825 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1826 Rap1 signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1827 Rap1 signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1828 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1829 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1830 Rap1 signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1831 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1832 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1833 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1834 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1835 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1836 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1837 Rap1 signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1838 Rap1 signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1839 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1840 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1841 Ras signaling pathway 💬
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1842 Ras signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1843 Ras signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1844 Ras signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1845 Ras signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1846 Ras signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1847 Ras signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1848 Ras signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1849 Ras signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1850 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1851 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1852 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1853 Ras signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1854 Ras signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1855 Ras signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1856 Ras signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1857 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1858 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1859 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1860 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1861 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1862 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1863 Ras signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1864 Ras signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1865 Regulation of actin cytoskeleton 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1866 Regulation of actin cytoskeleton 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1867 Regulation of actin cytoskeleton 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1868 Regulation of actin cytoskeleton 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1869 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1870 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1871 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1872 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1873 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1874 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1875 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1876 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1877 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1878 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1879 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1880 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1881 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1882 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1883 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1884 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1885 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1886 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1887 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1888 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1889 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1890 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1891 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1892 Regulation of lipolysis in adipocytes 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1893 Relaxin signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1894 Relaxin signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1895 Relaxin signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1896 Relaxin signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1897 Relaxin signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1898 Relaxin signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1899 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1900 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1901 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1902 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1903 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1904 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1905 Relaxin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1906 Relaxin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1907 Relaxin signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1908 Relaxin signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1909 Renal cell carcinoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1910 Renal cell carcinoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1911 Renal cell carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1912 Renal cell carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1913 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1914 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1915 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1916 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1917 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1918 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1919 Renal cell carcinoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1920 Renal cell carcinoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
1921 Renal cell carcinoma 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1922 Renal cell carcinoma 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1923 Retrograde endocannabinoid signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1924 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1925 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1926 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1927 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1928 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1929 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1930 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1931 Rheumatoid arthritis 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1932 Rheumatoid arthritis 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
1933 Rheumatoid arthritis 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
1934 Rheumatoid arthritis 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1935 Rheumatoid arthritis 💬
1件: FLT1 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1936 Rheumatoid arthritis 💬
1件: FLT1 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1937 Rheumatoid arthritis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1938 Rheumatoid arthritis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1939 Rheumatoid arthritis 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1940 Rheumatoid arthritis 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1941 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1942 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1943 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1944 Salmonella infection 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1945 Salmonella infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1946 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1947 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1948 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1949 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1950 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1951 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1952 Salmonella infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1953 Salmonella infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1954 Salmonella infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1955 Salmonella infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1956 Salmonella infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1957 Salmonella infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine sulfate 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1958 Salmonella infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Vincristine 💬 Vincristine 5件: 26, 34, 63, 65, 331 💬
1959 Serotonergic synapse 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1960 Serotonergic synapse 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1961 Serotonergic synapse 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1962 Serotonergic synapse 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1963 Serotonergic synapse 💬
3件: GABRB1, GABRB2, GABRB3 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1964 Serotonergic synapse 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1965 Serotonergic synapse 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1966 Serotonergic synapse 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1967 Serotonergic synapse 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1968 Serotonergic synapse 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1969 Serotonergic synapse 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1970 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1971 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1972 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1973 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1974 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1975 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1976 Serotonergic synapse 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1977 Shigellosis 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1978 Shigellosis 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1979 Shigellosis 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1980 Shigellosis 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1981 Shigellosis 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1982 Shigellosis 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1983 Shigellosis 💬
2件: IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1984 Shigellosis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
1985 Shigellosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1986 Shigellosis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1987 Shigellosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
1988 Shigellosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1989 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1990 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1991 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1992 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1993 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1994 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1995 Signaling pathways regulating pluripotency of stem cells 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1996 Signaling pathways regulating pluripotency of stem cells 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1997 Small cell lung cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1998 Small cell lung cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
1999 Small cell lung cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
2000 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2001 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2002 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2003 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2004 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2005 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2006 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2007 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2008 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2009 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2010 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2011 Sphingolipid signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2012 Sphingolipid signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2013 Sphingolipid signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2014 Sphingolipid signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2015 Sphingolipid signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2016 Spinocerebellar ataxia 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
2017 Spinocerebellar ataxia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2018 Spinocerebellar ataxia 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2019 Staphylococcus aureus infection 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2020 Synaptic vesicle cycle 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
2021 Synaptic vesicle cycle 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
2022 Systemic lupus erythematosus 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2023 Systemic lupus erythematosus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2024 Systemic lupus erythematosus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2025 T cell receptor signaling pathway 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
2026 T cell receptor signaling pathway 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2027 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2028 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2029 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2030 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2031 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2032 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2033 T cell receptor signaling pathway 💬
1件: PDCD1 💬 Retifanlimab 💬 Retifanlimab 1件: 34 💬
2034 T cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2035 T cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2036 T cell receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2037 T cell receptor signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2038 Taste transduction 💬
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
2039 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lamotrigine 💬 Lamotrigine 7件: 13, 34, 38, 113, 114, 115, 144 💬
2040 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2041 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2042 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2043 Taurine and hypotaurine metabolism 💬
2件: GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2044 Taurine and hypotaurine metabolism 💬
2件: GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2045 Taurine and hypotaurine metabolism 💬
2件: GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2046 Terpenoid backbone biosynthesis 💬
2件: FNTA, FNTB 💬 Tipifarnib 💬 Tipifarnib 1件: 34 💬
2047 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
2048 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 22件:  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
2049 TGF-beta signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2050 TGF-beta signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2051 TGF-beta signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2052 Th17 cell differentiation 💬
2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2053 Th17 cell differentiation 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2054 Th17 cell differentiation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
2055 Th17 cell differentiation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2056 Th17 cell differentiation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2057 Thermogenesis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
2058 Thermogenesis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2059 Thermogenesis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2060 Thyroid cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2061 Thyroid cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
2062 Thyroid cancer 💬
2件: BRAF, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2063 Thyroid cancer 💬
2件: BRAF, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2064 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2065 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2066 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2067 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2068 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2069 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2070 Thyroid cancer 💬
1件: RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2071 Thyroid cancer 💬
1件: RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2072 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2073 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2074 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2075 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2076 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2077 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2078 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
2079 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2080 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2081 Thyroid hormone signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2082 Thyroid hormone signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2083 Tight junction 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
2084 Tight junction 💬
1件: ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
2085 Tight junction 💬
1件: ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
2086 Tight junction 💬
1件: ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
2087 Tight junction 💬
1件: ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
2088 TNF signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2089 TNF signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2090 TNF signaling pathway 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2091 TNF signaling pathway 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2092 TNF signaling pathway 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2093 TNF signaling pathway 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2094 TNF signaling pathway 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2095 TNF signaling pathway 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2096 TNF signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
2097 TNF signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
2098 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2099 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2100 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2101 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2102 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2103 TNF signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2104 Toll-like receptor signaling pathway 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2105 Toll-like receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2106 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2107 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2108 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2109 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2110 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2111 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2112 Toll-like receptor signaling pathway 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
2113 Toll-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2114 Toxoplasmosis 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2115 Toxoplasmosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2116 Toxoplasmosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2117 Transcriptional misregulation in cancer 💬
3件: CSF1R, FLT1, FLT3 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2118 Transcriptional misregulation in cancer 💬
3件: CSF1R, FLT1, FLT3 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2119 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
2120 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
2121 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
2122 Transcriptional misregulation in cancer 💬
1件: FLT3 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2123 Transcriptional misregulation in cancer 💬
1件: FLT3 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2124 Transcriptional misregulation in cancer 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2125 Transcriptional misregulation in cancer 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2126 Transcriptional misregulation in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
2127 Transcriptional misregulation in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
2128 Tuberculosis 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2129 Tuberculosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2130 Tuberculosis 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2131 Tuberculosis 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2132 Tuberculosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2133 Tuberculosis 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
2134 Type I diabetes mellitus 💬
2件: GAD1, GAD2 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2135 Type I diabetes mellitus 💬
2件: GAD1, GAD2 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2136 Type I diabetes mellitus 💬
2件: GAD1, GAD2 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2137 Type I diabetes mellitus 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2138 Type I diabetes mellitus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2139 Type I diabetes mellitus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2140 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2141 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2142 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2143 Type II diabetes mellitus 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 12件: 34, 67, 89, 96, 137, 157, 158, 228, 277, 278, 279, 280 💬
2144 Type II diabetes mellitus 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2145 Type II diabetes mellitus 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2146 Type II diabetes mellitus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2147 Type II diabetes mellitus 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2148 Type II diabetes mellitus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2149 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2150 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2151 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 11件:  3 ,  5 , 26, 34, 51, 65, 89, 90, 145, 222, 331 💬
2152 Vascular smooth muscle contraction 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2153 Vascular smooth muscle contraction 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
2154 Vascular smooth muscle contraction 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2155 Vascular smooth muscle contraction 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2156 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2157 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2158 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2159 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2160 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2161 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2162 VEGF signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
2163 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
2164 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
2165 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
2166 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
2167 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2168 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2169 VEGF signaling pathway 💬
2件: KDR, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2170 VEGF signaling pathway 💬
2件: KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2171 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2172 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2173 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2174 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2175 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2176 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2177 VEGF signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
2178 VEGF signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
2179 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2180 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2181 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2182 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2183 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
2184 VEGF signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
2185 VEGF signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
2186 Viral carcinogenesis 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
2187 Viral myocarditis 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2188 Viral myocarditis 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2189 Viral myocarditis 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
2190 Viral protein interaction with cytokine and cytokine receptor 💬
4件: CCL2, IL10, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2191 Viral protein interaction with cytokine and cytokine receptor 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2192 Viral protein interaction with cytokine and cytokine receptor 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2193 Viral protein interaction with cytokine and cytokine receptor 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2194 Viral protein interaction with cytokine and cytokine receptor 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
2195 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
2196 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
2197 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
2198 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
2199 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
2200 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
2201 Yersinia infection 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2202 Yersinia infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2203 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2204 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2205 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2206 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2207 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2208 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2209 Yersinia infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬